Stay updated on Semaglutide vs Placebo in PAD and T2D Clinical Trial
Sign up to get notified when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.

Latest updates to the Semaglutide vs Placebo in PAD and T2D Clinical Trial page
- Check7 days agoChange DetectedRecord History now shows Revision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.4.2 was added to the record history. Revision: v3.4.1 was removed along with the government-funding lapse notice.SummaryDifference0.3%

- Check42 days agoChange DetectedA site-wide funding notice was added. Revision: v3.4.1 was introduced and the previous Revision: v3.4.0 was removed.SummaryDifference0.3%

- Check49 days agoChange DetectedUI updates on the history page introduce a glossary display and color-coded change highlights (green for additions, red for deletions) along with updated labels such as No FEAR Act data and revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedRevision history updated from v3.3.3 to v3.3.4; this is an administrative update and does not alter the study's content or results.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision: v3.3.3 was added to the history. The footer now excludes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

Stay in the know with updates to Semaglutide vs Placebo in PAD and T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.